Compare TELA & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TELA | EKSO |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3M | 37.9M |
| IPO Year | 2019 | 2012 |
| Metric | TELA | EKSO |
|---|---|---|
| Price | $0.86 | $11.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.00 | ★ $9.50 |
| AVG Volume (30 Days) | ★ 145.4K | 88.9K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.59 | ★ 41.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,275,000.00 | N/A |
| Revenue This Year | $10.23 | $81.23 |
| Revenue Next Year | $14.26 | $7.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $2.88 |
| 52 Week High | $2.19 | $13.50 |
| Indicator | TELA | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 60.17 |
| Support Level | $0.79 | $8.30 |
| Resistance Level | $0.91 | $12.39 |
| Average True Range (ATR) | 0.10 | 0.86 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 39.13 | 79.44 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.